Protect your trial blind– and your fridge space

Keep clinical sites safely supplied — prevent fridge overload, monitor expiry dates, and automate reordering.

Randomisation to site delivery, stock management is fully traceable, compliant, and built to reduce manual workload.

Stock Management

  • Spinnaker sends requests to the warehouse or manufacturer with blind-safe IDs — not treatment names.

  • Predict site demand based on enrollment and trial milestones.

  • Spinnaker uses defined storage limits and triggers resupply automatically when stock runs low.

  • Confirm deliveries and record any issues. Damaged stock is removed immediately.

  • Spinnaker skips expired stock and only allocates valid units at randomisation.

  • Sites can track stock levels without exposing treatment groups or breaking the blind.

  • Extra doses are issued per protocol — matched to the original treatment.

  • From destruction order—every step is recorded and searchable.

“I like stock control living inside Spinnaker because you can actually see what’s going on and act fast — especially in a double-blind trial. Check-in and audits are straightforward, and reordering or resupply takes a few clicks. It saves the trial team a heap of time.”


Audrey Shearer, Founder & CEO, Spiral Software.

MEET AUDREY

“We knew study drug inventory needed to be robust but straightforward. Spinnaker ensures trial teams only access blinded or unblinded stock details relevant to their role and site — always current, always secure. With automatic pharmacy orders, instant order status updates, and two‑click validated inventory imports, managing study drug is streamlined and stress‑free.”


Amanda Daley, Product Owner, Spiral Software.

MEET AMANDA

Engage early

Bringing Spiral in early means your stock control is built into the platform from the start — aligned with your protocol, enrolment flow, and site-specific limits. That gives your team clear visibility, faster resupply, and fewer delays when it matters.

Stay Connected with Spiral

Never miss a bit or a byte! Join us for industry insights, sector events, novel trial advancements, and more.